Financial Statements — SPEGU
Balance Sheet
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q3
2025 | Q2
2025 |
|---|
| Cash & Equivalents | 0.16 | 0.24 | 0.45 | -- |
| Short-term Investments | 119.18 | 118.14 | 115.99 | -- |
| Total Current Assets | 0.26 | 0.40 | 0.63 | 0.00 |
| Total Non-current Assets* | 119.18 | 118.14 | 116.02 | 0.28 |
| Total Assets | 119.44 | 118.53 | 116.65 | 0.28 |
| Accounts Payable | 0.07 | 0.08 | 0.03 | 0.00 |
| Total Current Liabilities | 0.14 | 0.15 | 0.11 | -- |
| Total Non-current Liabilities* | 9.16 | 8.21 | 8.39 | -- |
| Total Liabilities | 9.30 | 8.37 | 8.50 | 0.35 |
| Retained Earnings | (9.05) | (7.97) | (7.84) | (0.10) |
| Total Stockholder Equity | (9.05) | (7.97) | (7.84) | (0.07) |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 |
|---|
| Selling, General & Admin | 0.13 | 0.15 | 0.15 | 0.18 | 0.02 |
| Operating Income | (0.13) | (0.15) | (0.15) | (0.18) | (0.02) |
| Net Income | (0.03) | 1.00 | 1.02 | (0.97) | (0.02) |
| Basic EPS | -- | -- | -- | -- | (0.01) |
| Diluted EPS | -- | -- | -- | -- | (0.01) |
Cash Flow Statement
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 |
|---|
| Operating Cash Flow | (0.08) | (0.14) | (0.07) | (0.34) |
| Investing Cash Flow | -- | -- | -- | (115.00) |
| Financing Cash Flow | -- | -- | -- | 115.79 |
